Breaking News

The partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure in Ethiopia.

Genoptix terminated the merger agreement after an insufficient number of Rosetta shareholders voted in favor of the deal.

The company said 571,000 people were screened for colon cancer with its noninvasive Cologuard test in 2017.

With new sequences from ancient Botai and Eurasian horses, researchers pinned early domestication to an area north of Kazakhstan. 

The patent claims strategies for identifying optimal breeding combinations of crop plants or cattle within a breeding population.

Excluding the sale of the company's colorectal cancer patents to Exact Sciences, its 2017 revenues rose 13 percent.

The increased revenues were due primarily to cardiac immunoassay sales from the newly acquired Triage and BNP businesses as well as increased sales of rapid immunoassay products.

Using genomic data for hundreds of ancient Europeans, research teams retraced the spread of the Beaker complex culture as well as interactions between pastoralists and hunter-gatherers.

Pages

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.